More
    Guided Solutions - Connecting Talent With Innovation/div>

    Comphya raises CHF 7.5 million for neurostim to treat ED

    Comphya has closed an oversubscribed Series A round that brings its total equity raised to CHF 7.5 million (approximately $8.4 million). The company earmarked the funds to advance clinical programs for CaverSTIM, an implantable neurostimulation...

    Comphya raises CHF 7.5 million for neurostim to treat ED

    Comphya has closed an oversubscribed Series A round that brings its total equity raised to CHF 7.5 million (approximately $8.4 million). The company earmarked the...

    Piur Imaging closes $6.5m funding round for AI tomographic 3D ultrasound

    Piur Imaging, a medical device company focusing on AI-powered tomographic 3D ultrasound, has closed a 5.6-million-euro ($6.5 million) growth capital funding round. Aescuvest Capital Partners,...

    Synchrony Medical wins FDA nod for airway clearance system

    Synchrony Medical received FDA 510(k) clearance for its LibAirty airway clearance system. LibAirty addresses a need for patients with chronic lung diseases such as chronic...

    GS MedTech Funding Tracker – Neuros Medical, Restore Medical and more

    While the overall volume of deals in the MedTech space is entering a summer slump, amazing funding rounds continue to support innovative technology. A...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    PanTher Therapeutics launches second trial for chemotherapy patch

    US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The Phase Ib study (NCT06673017)...

    InterShunt enrolls first patient in heart failure treatment study

    InterShunt Technologies announced it began an early feasibility study of its device for reducing heart failure symptoms. Dr. Sitaramesh Emani and the Structural Heart Intervention...

    Foldax presents positive data for its Tria polymer mitral heart valve

    Foldax announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering. In a trial based in India, the mitral valve...

    STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation

    STENTiT, a pioneering medical device company, developing a novel class of stents with regenerative properties, today announced the successful implantation of its Resorbable Fibrillated...

    Innovation

    Regulatory Approvals

    Comphya raises CHF 7.5 million for neurostim to treat ED

    Comphya has closed an oversubscribed Series A round that brings its total equity raised to CHF 7.5 million (approximately $8.4 million). The company earmarked the...

    Piur Imaging closes $6.5m funding round for AI tomographic 3D ultrasound

    Piur Imaging, a medical device company focusing on AI-powered tomographic 3D ultrasound, has closed a 5.6-million-euro ($6.5 million) growth capital funding round. Aescuvest Capital Partners,...

    Synchrony Medical wins FDA nod for airway clearance system

    Synchrony Medical received FDA 510(k) clearance for its LibAirty airway clearance system. LibAirty addresses a need for patients with chronic lung diseases such as chronic...

    GS MedTech Funding Tracker – Neuros Medical, Restore Medical and more

    While the overall volume of deals in the MedTech space is entering a summer slump, amazing funding rounds continue to support innovative technology. A...

    M&A

    Archives

    Latest articles